Search Results - "Khaertynova, Ilsiyar"

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors by Hammitt, Laura L., Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J., Tytus, Richard, Reddy, K. Rajender, Abarca, Katia, Khaertynova, Ilsiyar M., Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Shekar, Tulin, Fu, Wei, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K.

“…Immunocompetent adults with certain medical and behavioral factors are at increased risk of pneumococcal disease. In some countries, sequential vaccination…”
Get full text

Long Term Immune Response Produced by the SputnikV Vaccine by Martynova, Ekaterina, Hamza, Shaimaa, Garanina, Ekaterina E., Kabwe, Emmanuel, Markelova, Maria, Shakirova, Venera, Khaertynova, Ilsiyar M., Kaushal, Neha, Baranwal, Manoj, Rizvanov, Albert A., Urbanowicz, Richard A., Khaiboullina, Svetlana F.

“…SputnikV is a vaccine against SARS-CoV-2 developed by the Gamaleya National Research Centre for Epidemiology and Microbiology. The vaccine has been shown to…”
Get full text

Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients by Garanina, Ekaterina, Hamza, Shaimaa, Stott-Marshall, Robert J, Martynova, Ekaterina, Markelova, Maria, Davidyuk, Yuriy, Shakirova, Venera, Kaushal, Neha, Baranwal, Manoj, Khaertynova, Ilsiyar M, Rizvanov, Albert, Foster, Toshana L, Khaiboullina, Svetlana

“…Identifying immunogenic targets of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is critical to advance diagnostic and disease control…”
Get full text

Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia by Hamza, Shaimaa, Martynova, Ekaterina, Garanina, Ekaterina, Shakirova, Venera, Bilalova, Alisa, Moiseeva, Svetlana, Khaertynova, Ilsiyar, Ohlopkova, Olesia, Blatt, Nataliya, Markelova, Maria, Khaiboullina, Svetlana

“…The severity of COVID-19 is a result of the complex interplay between various branches of the immune system. However, our understanding of the role of…”
Get full text

Urinary Clusterin Is Upregulated in Nephropathia Epidemica by Tazetdinova, Leisan G., Valiullina, Aygul H., Khaiboullina, Svetlana F., Abiola, Ilesanmi M., Ivanova, Vilena V., Anokhin, Vladimir V., Khaertynova, Ilsiyar, Abdulkhakov, Sayar, Shakirova, Venera G., Maksudova, Adelya N., Martynova, Ekaterina V., Garanina, Ekaterina E.

“…Kidney insufficiency is a hallmark of nephropathia epidemica (NE). Little is known about the mechanisms of the NE kidney pathology, with current knowledge…”
Get full text

Characterization of the Puumala orthohantavirus Strains in the Northwestern Region of the Republic of Tatarstan in Relation to the Clinical Manifestations in Hemorrhagic Fever With Renal Syndrome Patients by Davidyuk, Yuriy N., Kabwe, Emmanuel, Shakirova, Venera G., Martynova, Ekaterina V., Ismagilova, Ruzilya K., Khaertynova, Ilsiyar M., Khaiboullina, Svetlana F., Rizvanov, Albert A., Morzunov, Sergey P.

“…Over 1,000 cases of hemorrhagic fever with renal syndrome (HFRS) were recorded in the Republic of Tatarstan (RT) in 2015. HFRS is a zoonotic disease caused by…”
Get full text

Factors associated with fibro-cavernous tuberculosis by Abilbayeva, Arailym, Tarabayeva, Anel, Myrkassymova, Akbope, Abubakirov, Amanzhan, Khaertynova, Ilsiyar, Shuralev, Eduard

“…Objective: To identify socio-demographic, clinical and laboratory risk factors associated with fibro-cavernous tuberculosis. Material and methods: Clinical and…”
Get full text

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY) by Hammitt, Laura L, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K

“…Abstract Background Adults with certain medical and behavioral factors are at increased risk for pneumococcal disease (PD). Sequential vaccination with…”
Get full text

Δ ccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica by Kletenkov, Konstantin, Martynova, Ekaterina, Davidyuk, Yuriy, Kabwe, Emmanuel, Shamsutdinov, Anton, Garanina, Ekaterina, Shakirova, Venera, Khaertynova, Ilsiyar, Anokhin, Vladimir, Tarlinton, Rachael, Rizvanov, Albert, Khaiboullina, Svetlana, Morzunov, Sergey

“…Nephropathia Epidemica (NE), a mild form of hemorrhagic fever with renal syndrome (HFRS) and linked to hantavirus infection, is endemic in the Republic of…”
Get full text

High Triglycerides Are Associated with Low Thrombocyte Counts and High VEGF in Nephropathia Epidemica by Khaiboullina, Svetlana F., Rizvanov, Albert A., Khaertynova, Ilsiyar, Shakirova, Venera G., Garanina, Ekaterina E., Davidyuk, Yuriy N., Gusev, Oleg A., Valiullina, Aygul H., Martynova, Ekaterina V., Anokhin, Vladimir V.

“…Nephropathia epidemica (NE) is a mild form of hemorrhagic fever with renal syndrome. Several reports have demonstrated a severe alteration in lipoprotein…”
Get full text

Extraction and Serological Properties of Mycobacterium Cell Surface and Excreted Proteins by Khaertynov, Kamil S., Valeeva, Anna R., Ivanov, Arkadiy V., Mukminov, Malik N., Urazov, Nail G., Khaertynova, Ilsiyar M., Aleksandrova, Natalya M., Moskvicheva, Albina V., Efimova, Marina A., Akhmadeev, Rafail M., Samigullina, Elvira S., Nabatov, Alexey A., Shuralev, Eduard A.

“…Modern medicine still faces the task of distinguishing active and latent tuberculosis cases at the early stage of the disease. Serological approaches have…”
Get full text

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial by Wedemeyer, Heiner, Schöneweis, Katrin, Bogomolov, Pavel, Blank, Antje, Voronkova, Natalia, Stepanova, Tatiana, Sagalova, Olga, Chulanov, Vladimir, Osipenko, Marina, Morozov, Viacheslav, Geyvandova, Natalia, Sleptsova, Snezhana, Bakulin, Igor G, Khaertynova, Ilsiyar, Rusanova, Marina, Pathil, Anita, Merle, Uta, Bremer, Birgit, Allweiss, Lena, Lempp, Florian A, Port, Kerstin, Haag, Mathias, Schwab, Matthias, zur Wiesch, Julian Schulze, Cornberg, Markus, Haefeli, Walter E, Dandri, Maura, Alexandrov, Alexander, Urban, Stephan

“…Bulevirtide is a first-in-class peptidic entry inhibitor for hepatitis B virus (HBV) and hepatitis D virus infection. In July, 2020, bulevirtide 2 mg received…”
Get full text

Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens by Shkair, Layaly, Sharma, Diksha, Hamza, Shaimaa, Garanina, Ekaterina, Shakirova, Venara, Khaertynova, Ilsiyar, Markelova, Maria, Pavelkina, Vera, Rizvanov, Albert, Khaiboullina, Svetlana, Baranwal, Manoj, Martynova, Ekaterina

“…Nephropathia epidemica (NE), caused by Puumala (PUUV) orthohantavirus, is endemic in the Republic of Tatarstan (RT). There are limited options for NE…”
Get full text

Identification and validation of cross-reactivity of anti-Thailand orthohantavirus nucleocapsid peptides by Hamza, Shaimaa, Shakirova, Venara, Khaertynova, Ilsiyar, Markelova, Maria, Saxena, Prakhar Vaidant, Sharma, Diksha, Kaushal, Neha, Gupta, Yogita, Garanina, Ekaterina, Pavelkina, Vera, Khaiboullina, Svetlana, Martynova, Ekaterina, Rizvanov, Albert, Baranwal, Manoj

“…A Thailand orthohantavirus (THAIV) is endemic in Southeast Asia. This assumption is supported by isolation of THAIV from local small mammals. Also,…”
Get full text

Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial by Johnson, Matthew G., Strizki, Julie M., Brown, Michelle L., Wan, Hong, Shamsuddin, Hala H., Ramgopal, Moti, Florescu, Diana F., Delobel, Pierre, Khaertynova, Ilsiyar, Flores, José F., Fouche, Leon F., Chang, Shan-Chwen, Williams-Diaz, Angela, Du, Jiejun, Grobler, Jay A., Paschke, Amanda, De Anda, Carisa

“…Purpose Immunocompromised patients have a potentially increased risk for progression to severe COVID-19 and prolonged replication of SARS-CoV-2. This post hoc…”
Get full text

193 SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) by Schwarz, Kathleen B., Bezerra, Jorge, Choe, Byung-ho, Lin, Chuan-Hao, Abramov, Frida, Wang, Hongyuan, Liu, Yang, Flaherty, John F., Pacurar, Daniela, Kim, Kyung Mo, Khaertynova, Ilsiyar, Shalimar, Wu, Jia-Feng, Tandon, Manish, Rosenthal, Philip, Morozov, Viacheslav, Sokal, Etinne, Chang, Mei-Hwei

Get full text

Positive Correlation between Serum Tryglycerides and Pro-Inflammatory Cytokines in Hemorrhagic Fever with Renal Syndrome by Kletenkov, Konstantin, Valiullina, Aygul Kh, Martynova, Ekaterina V., Gusev, Oleg A., Davidyuk, Yuri, Garanina, Ekaterina E., Shakirova, Venera G., Khaertynova, Ilsiyar M., Anokhin, Vladimir A., Rizvanov, Albert, Khaiboullina, Svetlana

“…Hemorrhagic fever with renal syndrome (HFRS) is endemic in the Republic of Tatarstan. Clinically, it is characterized by kidney insufficiency and hemorrhagic…”
Get full text

1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults Aged 18–49 Years (PNEU-DAY): A Subgroup Analysis by Baseline Risk Factors by Hammitt, Laura, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K

“…Abstract Background Risk factors (RFs) for pneumococcal disease (PD) in immunocompetent individuals include comorbidities, behavioral habits, or living in a…”
Get full text

Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19 by Arribas, José R, Bhagani, Sanjay, Lobo, Suzana M, Khaertynova, Ilsiyar, Mateu, Lourdes, Fishchuk, Roman, Park, William Y, Hussein, Khetam, Kim, Sei Won, Ghosn, Jade, Brown, Michelle L, Zhang, Ying, Gao, Wei, Assaid, Christopher, Grobler, Jay A, Strizki, Julie, Vesnesky, Mary, Paschke, Amanda, Butterton, Joan R, De Anda, Carisa

“…BACKGROUND: Molnupiravir is an oral prodrug of β-D-N4-hydroxycytidine, active against SARS-CoV-2 in vitro and in animal models. We report data from the phase 2…”
Get more information

Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B by Schwarz, Kathleen, Bezerra, Jorge, Choe, Byung-Ho, Lin, Chuan-Hao, Abramov, Frida, Nguyen, Anh-Hoa, Liu, Yang, Leisegang, Rory, Flaherty, John F., Pacurar, Daniela, Kim, Kyung Mo, Khaertynova, Shalimar, Ilsiyar, Wu, Jia-Feng, Tandon, Manish, Rosenthal, Philip, Viacheslav, Morozov, Sokal, Etienne, Chang, Mei-Hwei

Get full text